In one of the "most rigorous clinical investigations of psychedelic drugs to date, researchers at Johns Hopkins and NYU have found that a single dose of psilocybin—the psychoactive compound in magic mushrooms—substantially diminished depression and anxiety in patients with advanced cancer"

See the source article by following the link below:
In one of the "most rigorous clinical investigations of psychedelic drugs to date, researchers at Johns Hopkins and NYU have found that a single dose of psilocybin—the psychoactive compound in magic mushrooms—substantially diminished depression and anxiety in patients with advanced cancer"